Amalgamated Financial’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Amalgamated Financial’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$1.14M	Buy	+5,480	New	+$903K	0.01%	1118

Other funds holding SWAV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Amalgamated Financial's SWAV Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Shockwave Medical, Inc. Common Stock (SWAV) in Q1 2022: 5,480 shares worth $1.14M. The stake represents 0.01% of the portfolio and ranks #1118 among its holdings.

308 funds tracked by Wall St. Rank hold SWAV as of Q1 2022.

Amalgamated Financial held 5,480 shares of Shockwave Medical, Inc. Common Stock worth $1.14M as of Q1 2022.
Shockwave Medical, Inc. Common Stock was a new Amalgamated Financial position in Q1 2022.
Shockwave Medical, Inc. Common Stock made up 0.01% of Amalgamated Financial's portfolio in Q1 2022, its #1118 holding.
308 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.